In the last few months, Concord Biotech has given a return of approximately 80% after the listing in the market. From the last few weeks, the Concord Biotech stock has been consolidating in a range below 13% from its all-time high. Thinking about investing in the stock, check the Concord Biotech share price target for 2024, 2025, and 2026.
The Concord Biotech company IPO issue price was Rs. 741 and the stock is listed at Rs. 900 as of 1 Oct 2023 the stock is trading at Rs. 1400 which is approx 56% above the listing price. 56% return from the stock is a very huge return in just a few months. This type of return was also expected as it is a good company.
In the Biotech industry, Concord Biotech company is one of the leading companies in the industry. There is only one competitor for the company i.e. Biocon. The market cap of Biocon is approximately Rs. 14,547 Crore as of now.
Related Posts:
- Jio Financial Services Share Price Target 2024, 2025, and 2026
- EKI Energy Share Price Target 2024, 2025, and 2026
- IRCTC Share Price Target 2024, 2025, and 2026
About Concord Biotech
Concord Biotech is an Indian Biopharma company that was founded in the year 2000. Mr. Ankur Vaid is its current managing director. The company manufactures pharmaceutical ingredients and supplies all over the world.
Concord Biotech works on API (Active pharmaceutical ingredients), manufacturing, and Contract research & finished Formulation. Concord Biotech has a presence in more than 70+ countries all over the world.
There are a very large number of API products on which they work and manufacture like Tacrolimus, Sirolimus, Mupirocin, Caspofungin, Mitomycin, Lovastatin, Midostatin, Romidepsin, and many more.
They are also working on many APIs like Nystatin, Pirarubicin, Idarubicin, Polymyxin B, Fidexomicin, and many more.
As we mentioned above they are also involved in Contract Research & Manufacturing of Biotech products. They have also many products in the Formulation (Regulated Market and Emerging Markets).
Company Fundamentals
From the fundamentals data, you can know about the company in detail like the strength of the company, the right value of the company, the position of the company among the all companies of the sector, financial statements, growth of the company, and many more.
Most probably you are a retail investor, it is highly recommended to do a fundamental analysis by yourself of the stocks in which you are investing or already invested. In case, you know how to do a fundamental analysis of companies you can learn it from the Internet.
Note: The fundamentals of the Concord Biotech company were last updated on 14 February 2024. Check the latest data on any broker website or screener.
Net Profit & Loss (Yearly)
| Year | Net Profit & Loss (In Crore) |
|---|---|
| March 2019 | NA |
| March 2020 | ₹169 |
| March 2021 | NA |
| March 2022 | ₹175 |
| March 2023 | ₹240 |
Net Profit & Loss (Quarterly)
| Quarter | Net Profit & Loss (In Crore) |
|---|---|
| Dec 2022 | ₹21.97 |
| Mar 2023 | ₹91.49 |
| Jun 2023 | ₹54.49 |
| Sep 2023 | ₹81.02 |
| Dec 2023 | ₹77.57 |
Company Essentials
| Market Cap | ₹14,547Cr | ROE | 22.47% |
| P/E Ratio (TTM) | 47.77 | EPS (TTM) | 29.11 |
| P/B Ratio | 10.74 | Div Yield | 0.49% |
| Industry P/E | 35.50 | Book Value | 129.45 |
| Debt to Equity | 0.02 | Face Value | 1 |
Shareholding Pattern
| Held By | Jun 2023 | Sep 2023 | Dec 2023 |
|---|---|---|---|
| FIIs | NA | 7.30% | 7.00% |
| DIIs | NA | 8.12% | 8.40% |
| Public | NA | 40.50% | 40.52% |
| Promoters | NA | 44.08% | 44.08% |
| Other Holders | NA | 0% | 0% |
Key Points
- On the compnay, there is very less DEBT i.e. Rs. 31.24 Crore.
- The compnay has cash of Rs. 43.45 Crore.
- Concord has more than 75+ products and a large number of brands that make it very powerful in the industry.
- In 2023, the compnay made a profit of Rs. 238 Crore which is higher than the profits of the last 5 years.
Quarterly Results
In the Dec 2023, the Concord Biotech compnay made a net profit of Rs. 77.57 Crore which is much higher than its previous quarter. But its yearly profit is growing very rapidly.
Rules for Investing
Investment rules play a major role in the life of an Investor to invest in the right stock, book profit at the right time, buy at the right time, sell at the right time, and many more… In a few words, it plays a major role in reducing risk in the stock market and maximizing profit.
These rules apply to the maximum sectors’ stocks. If you are new in the market or don’t have enough knowledge you should follow the rules to make your self psychology strong.
- Rule 1: Do not invest in penny stocks, if investing make sure most of the money is invested in the large-cap stock, large-cap mutual funds, etc. Penny stocks are very risky, especially for retail investors.
- Rule 2: Invest for the long term, at least 5 to 6 years. Investing for the long term reduces a lot of risk. It is confirmed that the market will go up in the long term.
- Rule 3: Do not invest in a lot of stocks, It will become very hard to analyze all the stocks regularly. So, invest in a limited number of stocks like 15 – 18 stocks only.
- Rule 4: Only invest in 1 – 2 stocks of a specific sector. In case, the stock faces any problem in the future your maximum investments will be safe.
- Rule 5: Investing in SIP mode will keep averaging your buying price with time and the return will be maximized as well.
- Rule 6: Invest only 5% to 6% in a single stock. In penny stocks, you should only invest in the 3% to 4%.
- Rule 7: You should have all the information about the stocks you invested like the company, company products & services, business model, company fundamentals, etc.
- Rule 8: Only invest or SIP in stocks only when it is available at a very high discount of 10% to 15% at least.
- Rule 9: When a stock in which you want to invest is near its all-time high and has the potential to go up, you should invest in the stock in SIP mode.
- Rule 10: Do not invest in those stocks, which are in trouble and have problems in the company fundaments especially in penny stocks.
Concord Biotech Share Price Target
There is very high potential in the Concord Biotech share that it will give very high returns in the upcoming months. Just after the listing, the stock has given up to 65% return because of its business model, strength of the company, etc.
Concord Biotech is the second-largest company in the Biotech industry by market cap. As the company doing business all over the world and has a big list of its products and services for the industry.
Disclaimer: We are not SEBI registered. The post is only for educational purposes not for any investing advice. Do your analysis or ask your financial advisor before investing. We will not be responsible for any loss or profit.
Concord Biotech share price target 2024
After making a new all-time high of Rs. 1607 the stock started falling and fell approx 15% in just a few months. This is why we do not recommend buying any stock when the stock is near its all-time high. After the fall the stock consolidated for a few days and again started going up.
It is a very huge and good opportunity to take a short-term trade with a stop loss of Rs. 1350. As it is a very strong support then the Concord Biotech share will take a long time to break in case of any reversal.
There are two targets for the stock i.e. near its all-time high Rs. 1600 and the second is Rs. 1650. Most probably its first target can be achieved in just a few weeks.
Concord Biotech share price target 2025 and 2026
For the long term, the Concord Biotech stock is one of the best stocks in the industry. Concord Biotech is one of the leading companies in the industry and stands at no. 2 in terms of market cap in India.
As we already mentioned above there are no patterns formed in the chart that suggest any signal. So, you should wait for a pattern to buy it at the right price to get higher returns.
The Concord Biotech stock is trading near an all-time high and keeps going up because of the high demand for the stock. Once the investors will get good profits from the stocks they will start booking the profit and the stock will go down very badly.
So, as per investing rule do not invest in any stock which is near an all-time high, newly listed, etc. Let the stock price be stable and then invest in the stock when it is available at least a 10% discount from the all-time high.
FAQs
Yes, Concord Biotech is one of the largest companies in the biotech industry has a large number of products in different categories, and is present in more than 70+ countries. So, no doubt the company is good and give good results in the future.
As the stock price is very high and keeps going up so, you can invest in the stock only when the stock is available at a high discount, the stock price is stable, etc.
There are very high chance that the stock can give a good profit in the year 2024 because of the business model and last quarter’s results. Always remember the company is a mid-cap company so, in the sock the volatility can be very high in the worst crash in the market.
There is no doubt that Concord Biotech is a good company and very stable in the industry. There is some competition for the company but they are already out of the competition.
They provide many services and products all over the world and do business in more than 70 countries. They achieved the number with their hard work and dedication.
Final Words: Concord Biotech company is one of the leading companies in the manufacturing of biotech products for the world. Fundamentally the company is very strong and stable but as its IPO was listed recently it can be volatile. Due the the high growth of the company, the Concord Botech stock has given more than 56% return. For the long term, the Concord share price target can be really big.